BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12628080)

  • 1. Cardiovascular consequences of obesity.
    Okerberg K; Hamilton Dougherty A
    Curr Womens Health Rep; 2003 Apr; 3(2):110-5. PubMed ID: 12628080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity: new perspectives and pharmacotherapies.
    Palamara KL; Mogul HR; Peterson SJ; Frishman WH
    Cardiol Rev; 2006; 14(5):238-58. PubMed ID: 16924165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and cardiovascular risk: the new public health problem of worldwide proportions.
    Scaglione R; Argano C; Di Chiara T; Licata G
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):203-12. PubMed ID: 15151469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical management of obesity: an update.
    Karam JG; El-Sayegh S; Nessim F; Farag A; McFarlane SI
    Minerva Endocrinol; 2007 Sep; 32(3):185-207. PubMed ID: 17912157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and strategies in managing cardiometabolic risk.
    Repas TB
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin and cardiovascular diseases.
    Luo JD; Zhang GS; Chen MS
    Drug News Perspect; 2005 Sep; 18(7):427-31. PubMed ID: 16362081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin signaling and obesity: cardiovascular consequences.
    Yang R; Barouch LA
    Circ Res; 2007 Sep; 101(6):545-59. PubMed ID: 17872473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction.
    Douketis JD; Sharma AM
    Semin Vasc Med; 2005 Feb; 5(1):25-33. PubMed ID: 15968577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of obesity in menopause: diet, exercise, pharmacotherapy and bariatric surgery.
    Mastorakos G; Valsamakis G; Paltoglou G; Creatsas G
    Maturitas; 2010 Mar; 65(3):219-24. PubMed ID: 20044222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
    Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy for obesity.
    Dickerson LM; Carek PJ
    Am Fam Physician; 2000 Apr; 61(7):2131-8, 2143. PubMed ID: 10779254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
    Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of obesity: medical treatment options.
    Carek PJ; Sherer JT; Carson DS
    Am Fam Physician; 1997 Feb; 55(2):551-8, 561-2. PubMed ID: 9054224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
    Ballantyne CM
    Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors in young, overweight, and obese European adults and associations with physical activity and omega-3 index.
    Ramel A; Pumberger C; Martinéz AJ; Kiely M; Bandarra NM; Thorsdottir I
    Nutr Res; 2009 May; 29(5):305-12. PubMed ID: 19555811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study).
    Murphy NF; MacIntyre K; Stewart S; Hart CL; Hole D; McMurray JJ
    Eur Heart J; 2006 Jan; 27(1):96-106. PubMed ID: 16183687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
    Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive endocrinology and clinical aspects of obesity in women.
    Metwally M; Ledger WL; Li TC
    Ann N Y Acad Sci; 2008 Apr; 1127():140-6. PubMed ID: 18443342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, health issues, and cardiovascular disease.
    Van Gaal LF; Michiels JJ
    Semin Vasc Med; 2005 Feb; 5(1):1-2. PubMed ID: 15968574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.